Citadel Advisors - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is and the CUSIP is 00444T950. A total of 4 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$63,000
+142.3%
20,300
+203.0%
0.00%
Q4 2015$26,000
-65.8%
6,700
-73.2%
0.00%
Q3 2015$76,000
-43.3%
25,000
-21.1%
0.00%
Q2 2015$134,000
+306.1%
31,700
+268.6%
0.00%
Q1 2015$33,000
+94.1%
8,600
+230.8%
0.00%
Q4 2014$17,000
-65.3%
2,600
-70.8%
0.00%
Q3 2014$49,000
-84.8%
8,900
-71.7%
0.00%
Q2 2014$322,000
+1794.1%
31,400
+2142.9%
0.00%
Q1 2014$17,0001,4000.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 49,500$210,0000.00%
SABBY MANAGEMENT, LLC 186$79,0000.00%
SIMPLEX TRADING, LLC 102$13,0000.00%
Citadel Advisors 31,700$134,0000.00%
View complete list of ACELRX PHARMACEUTICALS INC shareholders